Company Overview: Fibrocell

Industry News

28 Mar

Fibrocell Regains Compliance with NASDAQ Listing Requirements

EXTON, Pa., March 28, 2017 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that it received notice from The NASDAQ Stock Market LLC (NASDAQ) on March 27, 2017 indicating that the Company...

Read more

26 Jul


The Leader in Autologous Fibroblast Therapies At the forefront of personalized biologics Fibrocell, a cell and gene therapy company, is focused on diseases affecting the skin and connective tissue. Our approach to personalized biologics is distinctive based on our proprietary autologous fibroblast technology. By extracting fibroblast cells from a...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets


Follow this blog

Get every new post delivered right to your inbox.

Email address